Cargando…

Codeine-containing medicines to be reclassified in NZ

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648239/
http://dx.doi.org/10.1007/s40278-020-85591-0
_version_ 1783607075058745344
collection PubMed
description
format Online
Article
Text
id pubmed-7648239
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76482392020-11-09 Codeine-containing medicines to be reclassified in NZ Reactions Weekly News Item Springer International Publishing 2020-11-07 2020 /pmc/articles/PMC7648239/ http://dx.doi.org/10.1007/s40278-020-85591-0 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
Codeine-containing medicines to be reclassified in NZ
title Codeine-containing medicines to be reclassified in NZ
title_full Codeine-containing medicines to be reclassified in NZ
title_fullStr Codeine-containing medicines to be reclassified in NZ
title_full_unstemmed Codeine-containing medicines to be reclassified in NZ
title_short Codeine-containing medicines to be reclassified in NZ
title_sort codeine-containing medicines to be reclassified in nz
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648239/
http://dx.doi.org/10.1007/s40278-020-85591-0